Search Results

GPCRs continue to be regarded as one of the most tractable classes of drug targets and are targeted by 30%–40% of current drugs (Hauser et al., 2017), with annual sales of GPCR-targeting drugs in 2018 accounting Despite this high number of GPCR targeted drugs, only a small portion (∼110) of the human GPCRome (consisting of approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective Read more at the source #DrGPCR #GPCR #IndustryNews

Watch Episode 175 If your model can’t predict the future of GPCR drug discovery, why build it at all? insights not just to explain receptor–ligand interactions after the fact, but to forecast outcomes and design When existing compounds are exhausted, bespoke ligands are designed and synthesized in-house. Can we design compounds that trigger biased signaling? But part of their rigor lies in restraint. GPCR Premium Ecosystem  for advanced insights into structure-based modeling, ligand design, and experimental

Welcome GPCR Fans,   In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug Ingo Hartung : State-of-the-art design of small molecule drugs, including PROTACs Dr. His leadership principles: Hire for attitude and team fit—not just credentials Design workflows that GPCR Premium is designed for scientists who need the right intelligence, fast—without noise, distractions

drugs in treating a range of health conditions, from cancer and genetic disorders to inflammation and to that star are Verily and Sosei Heptares, which have struck a research agreement to discover new GPCR targets that’ll fuel the development of potential drug candidates. drug discovery have clocked in at $1 billion—with Genentech—and, just last November, $2.6 billion in Read more at the source #DrGPCR #GPCR #IndustryNews

Elevate Your GPCR Science with Essential Frameworks for Precision Drug Discovery: An Insight into Advanced , Not Breakdowns In the fast-paced world of GPCR drug discovery, the "go fast" mindset can often lead GPCR-Based Drug Discovery conference is where the future of GPCR therapies will be defined. lessons, classified industry news, priority event alerts, job opportunities, and insider commentary—all designed GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

of novel drugs, optimize drug design processes, and enhance the understanding of GPCR biology. De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding Multi-target drug design: GPCRs are often involved in complex signaling networks. With the revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively the process, optimizing drug design, and improving success rates.

allostery and biased signaling are redefining drug design The Long Arc of Chemical Pharmacology The early history of drug discovery was rooted in nature . Allostery and Biased Signaling Change the Game The most profound change in GPCR drug discovery is our GPCRs are not simple on/off switches. GPCR innovation is accelerating.

(Bikker et al., 1998) Quantitative studies of how drugs modulate their targets have been instrumental However, several challenges have limited the use of mutagenesis in drug discovery. In summary, mutagenesis can be a critical tool in drug discovery, particularly for studying GPCRs. G-protein coupled receptors: models, mutagenesis, and drug design. Molecular determinants of ligand efficacy and potency in GPCR signaling.

Months were spent debating assay design. IP1 isn’t naturally abundant or easy to detect. Eventually, the team landed on a design that could accumulate and detect IP1 in a 384-well format. David Parker spent years designing rare-earth europium probes. Trinquet’s team designed pHSense to detect that, without microscopy. It’s a strategic tool for decoding GPCR behavior in drug discovery and systems biology.

If your team is designing covalent or tight-binding candidates, these principles reduce surprises and Designing for penetration —balance on/off rates to reach inner tissue, not just peripheries. Watch our new trailers for a preview of expert-led GPCR training designed for scientists and drug hunters Kenakin… sorely needed in the field." — DrGPCR University Attendee 🚀 Join now — and learn to design field 🧠 Designed for researchers at every career stage

But the moment I designed my own experiment, I was hooked. By 2011, she had established her own group within the Drug Discovery Biology theme at Monash Institute Why GPCR Spatial Signaling Is Changing Drug Discovery Today, Michelle leads the Spatial Organization drug discovery and precision targeting. It’s a new language for drug discovery.

Snapshot of roles spanning PhD entry points to senior translational pharmacology—Protein Expression, Drug how construct design and solubilization choices shape success. GPCR innovation is accelerating. Aside from his vast experience in drug development, not to mention his extensive publication record, field 🧠 Designed for researchers at every career stage Don’t just keep up — lead the way 🚀 Join Premium

of the prime targets for marketed drugs. While traditional drug discovery programs have focused on the development of ligands targeting the binding current strategies for the identification of allosteric sites as well as ligand-based and structure-based drug discovery and design." Read more at the source #DrGPCR #GPCR #IndustryNews

Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery G-protein-coupled receptors GPCR dimers are therefore emerging drug targets in different therapeutic areas including depression, What is the potential of targeting GPCR dimer interface in drug discovery? GPCR drugs efficacy usually depends on a pathway (G protein or β-arrestin), whereas side effects are dimerization while accelerating drug discovery targeting GPCR dimers.

GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet to be explored.  35% of FDA-approved drugs target GPCRs, showing their importance in numerous physiological However, over half of non-sensory GPCRs do not have drugs available in the clinic, opening the door to Thus, rational design using efficient synthetic strategies is needed to make these probes as specific Our scientific team can guide you choose or design the right fluorescent ligand for your research.  

October 2022 GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches This approach can expand the repertoire of adenosine receptor antagonists that can be designed based Read more at the source #DrGPCR #GPCR #IndustryNews

Kenakin’s latest   lecture delivers exclusive, real-world insight designed to equip you to move beyond surface-level affinity data and make faster, more confident decisions in your drug discovery pipeline In this session, you’ll gain: ✅ A practical framework for understanding when a drug’s rate of binding truly reflects equilibrium—and when it doesn’t This is practical kinetic expertise—crafted to help drug s Corner   ______ #DrugDiscovery #Pharmacology #DrugKinetics #PipelineEfficiency #PharmaInnovation #GPCR

Broichhagen aka JB, the goal was bold and elegant: Create a photo-switchable ligand to remotely control GPCR They had a tool that did bind the GPCR… but not in the light-controlled way they wanted. For metabolic GPCRs (like GLP-1 and GIP receptors): Drug efficacy depends on which cells express the Clarify brain vs. peripheral contributions to metabolic therapy Guide how next-generation incretin drugs are designed Support cell-targeted conjugate therapeutic strategies It didn’t just solve a problem.

Nasdaq debutante Septerna swells its IPO to $331m Nxera Pharma and Antiverse Enter Collaboration To Design Therapeutics, Inc. has received Orphan Drug Designation (ODD) from the FDA for its hematopoietic stem Drugs like Ozempic will change the world GPCR Events, Meetings, and Webinars November 5 - 7, 2024 | 16th Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe NEW December of Advanced Multimodal Approaches to GPCR Drug Discovery NEW March 12 - 14, 2025 | NextGen Biomed 2025

Notably, G-protein-coupled receptors (GPCRs), representing the biggest drug target, have been revealed Historically, drug discovery efforts targeting GPCRs focused on G-protein-dependent signaling pathways drug discovery (Eishingdrelo & Kongsamut, 2013). Minireview: targeting GPCR activated ERK pathways for drug discovery. Biased receptor signaling in drug discovery. Pharmacological Reviews, 71(2), 267-315.

— a transformation that reshaped how scientists design experiments and interpret signaling. The field moved from single readouts to integrated signaling landscapes, accelerating drug discovery Today, success depends less on manual precision and more on experimental design, data interpretation, What started as hand-built assays on ice has become integrated platforms for drug discovery, systems GPCR Podcast 🔓 Get tools, deep dives, and exclusive insights with   Dr. GPCR Premium .

Rather than carving out turf, they grew by designing around collective capacity . techniques, not just one pipeline Senior scientists embedded as “connectors” between programs This design It was designed. Weekly seminars were mandatory but lightweight, designed to connect  rather than perform. This ecosystem design blueprint applies to biotech teams and academic consortia alike.

Why this matters Receptor distribution shapes incretin hormone drug effects across islets and neural Sparked a Scientific Journey Molecular Creativity in Drug Discovery Why Dr. publications, events, insights, and opportunities designed to support your career, your lab, or your Aside from his vast experience in drug development, not to mention his extensive publication record, GPCR Team

Are you ready to truly understand how pharmacologists predict whole-body drug response from a single Probability Models   This is practical drug development expertise from Terry’s 40+ years of experience GPCR News.   Elevate your pharmacology expertise. Unlock "Pharmacologic Models" now

depression, schizophrenia and Parkinson’s disease. [1,2] Several dopamine ligands have been approved as drugs Altogether, these aspects hint that the linker design and strategy can provide options for the tuning Current Drug Treatments Targeting Dopamine D3 Receptor. Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y1 Receptor. J. An Order of Magnitude Faster DNA-PAINT Imaging by Optimized Sequence Design and Buffer Conditions.

as the most important drug targets. Classically, GPCR internalization has been considered to lead to receptor desensitization. new understanding for the receptor internalization, the mechanism of physiology/pathology and novel drug , which will offer new insights into the regulatory mechanism of GPCR signaling and novel drug targets Read more at the source #DrGPCR #GPCR #IndustryNews

Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid If you’re building tools or careers in GPCR science, this is your playbook. It began with an unmet need: how to track Gq-coupled GPCR activity without the mess of calcium flux or GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

It’s a design space , not a binary choice, and penetration is just the beginning. Designing Strategically with Irreversible Drug Binding in Mind When irreversible mechanisms are designed but designing with them . 👉 Unlock Irreversible Drugs —  Only in Terry’s Corner! design. Kenakin with your own enzyme or GPCR interaction puzzles.

February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with co-founder "Jan 27, 2022 07:00am Septerna wants to spark a second golden age in G-protein-coupled receptor drug Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous with the target and analogizes the search for new drugs to oil drilling around the world." Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Ecosystem. A GPCR Internalization Tool Designed for Real Research Needs Built on more than two decade A GPCR Internalization Tool Designed for Real Research Needs s of GPCR assay innovation , pHSense™  was developed to overcome GPCR. GPCR Dr.